Supreme Court Considers Mandatory Nucleic Acid Test (NAT) for Safer Blood Transfusions
The Supreme Court has decided to examine whether blood banks should be mandated to conduct the Nucleic Acid Test (NAT) for identifying diseases like HIV, Hepatitis B, and Hepatitis C. Currently, the less sensitive Enzyme-Linked Immunosorbent Assay (ELISA) test is more common. The petition, filed by an NGO, argues that safe blood transfusion is a fundamental part of the Right to Life under Article 21. The move follows reports of children contracting HIV through contaminated blood transfusions during treatment for Thalassemia. The Court has asked for data on the cost-effectiveness and feasibility of implementing NAT in state-run hospitals.
Key Points
- NAT is a highly sensitive molecular technique that detects the genetic material of viruses, reducing the 'window period' for detection.
- The petition highlights that Thalassemia patients are particularly vulnerable due to frequent blood transfusions and contaminated blood risks.
- Article 21 of the Constitution (Right to Life) is being invoked to demand safer medical procedures across all state hospitals.
- The Court is investigating the financial burden on state hospitals if NAT is made mandatory compared to the current ELISA tests.
Exam Facts
- NAT stands for Nucleic Acid Test; ELISA stands for Enzyme-Linked Immunosorbent Assay.
- Article 21 of the Indian Constitution guarantees the Right to Life and Personal Liberty.
- Thalassemia is an inherited blood disorder where the body fails to produce enough hemoglobin.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.